The neurochemical basis of learning and neurocomputation: The redox theory

Behavioural Brain Research

Volumn 99, Issue 1, 1999, Pages 1-6

  Smythies, John ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamines; Glutamate synapse; Learning; Oxidative stress; Redox balance; ROS

Indexed keywords

ASCORBIC ACID; CARNOSINE; CATECHOLAMINE; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE;

LEARNING; MATHEMATICAL COMPUTING; NEUROCHEMISTRY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0033558166     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(98)00098-9     Document Type: Article

References (56)

1. Adlard BP, Moon S, Smart JL. Discrimination learning in ascorbic-acid deficient guinea pigs. Nature 1974;247:398.
2. Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 1995;64:718-23.
3. Bogerts B. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J Comp Neurol 1997;197:63-80.
4. Boldyrev AA, Stvolinsky SL, Tyulina OV, Koshelev VB, Hori N, Carpenter DO. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol 1997;17:259-71.
5. Cadet JL, Kahler LA. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci Biobehav Rev 1994;18:457-67.
6. Carlsson A, Waters N, Hansson LO. Neurotransmitter aberrations in schizophrenia: new findings. In: Fog R, Gerlach J, Hemmingsen R, editors. Schizophrenia. An integrated view. Copenhagen: Munksgard, 1994.
7. Chang JW, Coleman PD, O'Banion MK. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol Aging 1996;17:801-8.
8. Churchland P, Sejnowski T. The computational brain. Cambridge, MA: MIT Press, 1992.
9. Cook JA, Wink DA, Blount V, Krishna MC, Hanbauer I. Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity. Neurochem Intern 1996;28:609-17.
10. Cook-Mills JM, Cohen RL, Perlman RL, Chambers DA. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology 1995;85:544-9.
11. Costa C, Bertazzo A, Allegri G, Toffano G, Curcuruto G, Traldi P. Melanin biosynthesis from dopamine: II A mass spectrometric and collisional spectroscopic investigation. Pigment Cell Res 1992;5:122-31.
12. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disease. Science Wash 1993;262:689-95.
13. de Angelis L, Furlan C. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol Learn Mem 1995;64:119-24.
14. Dugan LL, Creedon DJ, Johnson EM Jr., Holtzman DM. Rapid suppression of free radical formation by nerve growth factor involves the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94:4086-91.
15. Dykens JA, Stern A, Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem 1987;49:1222-8.
16. Favit A, Sortino MA, Aleppo G, Scapagnini U, Canonico PL. Protection by dihydroergocryptine of glutamate-induced neurotoxicity. Pharmacol Toxicol 1993;73:224-8.
17. Fornstedt B, Carlsson A. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea-pig striatum. J Neurochem 1991;56:407-14.
18. Grof S. Clinical and experimental study of central effects of adrenochrome. J Neuropsychiatr 1963;5:33-50.
19. Hochstein P, Cohen G. The inhibitory effects of quinones and dipydric phenols on glucose metabolism in sub-cellular systems of brain. J Neurochem 1960;5:370-8.
20. Hoffer A, Osmond H, Smythies JR. Schizophrenia. A new approach. Part II. J Ment Sci 1953;100:29-45.
21. Ichitani Y, Okaichi H, Yoshikawa T, Ibata Y. Learning behaviour in chronic vitamin E-deficient and -supplemented rats; radial arm maze learning and passive avoidance response. Behav Br Res 1992;51:157-64.
22. Joseph MH, Hodges H. Lever pressing for food reward and changes in dopamine turnover and uric acid in rat caudate and nucleus accumbens studies chronically by in vivo voltammetry. J Neurosci Meth. 1990;34:143-9.
23. Kinsman RA, Hood J. Some behavioral effects of ascorbic acid deficiency. Am J Clin Nutr 1971;24:455-64.
24. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature (London) 1993;364:535-7.
25. Lanau F, Zenner M-T, Civelli O, Hartman DS. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 1997;68:804-12.
26. Liang CT, Sacktor B. The stimulation by catecholamines of guanylate cyclase activity in a cell-free ststem. J Cyclic Nucleotide Res 1978;4:97-111.
27. Lieb K, Andrae J, Reisert I, Pilgrim C. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Exp Neuurol 1995;134:222-9.
28. Liu J, Mori A. Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch Biochem Biophys 1993;302:118-27.
29. Matthews SB, Henderson AH, Campbell AK. The adrenochrome pathway: the major route for adrenalin catabolism by polymorphonuclear leucocytes. J Mol Cell Cardiol 1985;17:339-48.
30. Michel PP, Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 1990;26:428-35.
31. Murakami A, Tatsuno T, Kimura T, Noguchi H, Nakamura M. Regulation of nerve growth factor secretion in L-M cells by catechol derivatives. Neurosci Res 1993;17:71-5.
32. Napolitano A, Palumbo A, Misuraca G, Prota G. Inhibitory effect of melanin precursors on arachidonic acid peroxidation. Biochim Biophys Acta 1993;1168:175-80.
33. Ohmori T, Abekawa T, Koyama T. The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 1996;29:301-7.
34. Park JS, Bateman MC, Goldberg MP. Rapid alterations in dendritic morphology during sublethal hypoxia or glutamate receptor activation. Neurobiol Dis 1996;3:215-27.
35. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 1996;16:345-55.
36. Quartz SR, Sejnowski TJ. The neural basis of cognitive development: a constructivist manifesto. Behav Brain Sci 1998;20:537-556.
37. Rebec GV, Grabner CP, Johnson M, Pierce RC, Bardo MT. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neurocsience 1997;76:707-14.
38. Riedel G, Reymann KG. Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory. Acta Physiol Scand 1996;157:1-19.
39. Rothman SM, Olney JW. Excititoxicity and the NMDA receptor-still lethal after eight years. TINS 1995;18:57-8.
40. Sagratella S, de Carolis AS, Domenici MR, Lorenzini P, Fortuna S, Michalek H. Glutamate-dependent mechanisms in the induction of calcium long-term potentiation-like phenomena. Br Res Bull 1996;41:193-200.
41. Sampath D, Perez-Polo R. Regulation of antioxidant enzyme expression by NGF. Neurochem Res 1997;22:351-62.
42. Sassoe-Pognetto M, Cantino D, Panzanelli P, di Cantogno L V, Giustetto M, Margolis F, de Biasi L, Fasolo A. Presynaptic co-localization of carnosine and glutamate in olfactory neurons. NeuroReport 1993;5:7-10.
43. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr Op Neurobiol 1997;7:191-7.
44. Schwartz BE, Sem-Jacobsen C, Petersen MC. Effects of mescaline, LSD-25 and adrenochrome on depths electrograms in man. Arch Neurol Psychiatr 1956;75:579-87.
45. Schwartz BE, Wakim KG, Bickford R. Behavioral and electroencephalographic effects of hallucinogenic drugs: changes in cats on intraventricular injection. Arch Neurol Psychiatr 1956;75:83-90.
46. Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localizations in dendritic spines. Proc Natl Acad Sci USA 1994;91:5720-4.
47. Smythies JR. The biochemical basis of synaptic plasticity and neurocomputation: a new theory. Proc R Soc London B 1997;264:575-9.
48. Smythies JR. Oxidative reactions and schizophrenia: a review-discussion. Schiz Res 1997;24:357-64.
49. Smythies JR. Every person's guide to antioxidants. New Brunswick, NJ: Rutgers University Press, 1998.
50. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997;22:269-85.
51. Taborsky RG. Indoxyl derivatives: potential psychotropic metabolites. Int J Neuropharmacol 1968;7:483-6.
52. Taubman G, Jantz H. Untersuchung über die dem adrenochrom zugeschrieben psychotoxischen wirkungen. Nervenartz 1957;28:1957.
53. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996;87:1327-38.
54. Urabe K, Aroca P, Katsuhiko T, Mascagna D, Palumbo A, Prota G, Hearing VJ. The inherent toxicity of melanin precursors: a revision. Biochem Biophys Acta 1994;1221:272-8.
55. White HL, Wu JC. Properties of catechl o-methyl transferase from brain and liver of rat and human. Biochem J 1975;145:135-43.
56. Wolfe LS, Pappius HM, Marion J. The biosynthesis of prostaglandins by brain tissue in vitro. Adv Prostaglandin Thromboxane Res 1976;1:345-55.